Anybody can value anything at any price...the Stockhouse posts that were posted were representing trading numbers....if a stock isn’t liquid and marketable it doesn’t mean much.

Unless and until we get an IPO it’s all speculation but saying this...the Zenith story is really exciting....however it’s my speculative guess that this firm will have to go through all the trials first...just like RVX. Back in 2007 the rumor was that RVX would be sold “pre clinical” and the price went up to $29 per share.

Didn’t happen!